Avenir Corporation’s Antares Pharma, Inc. ATRS Stock Holding History

Avenir Corporation’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-302,852	Closed	-$1.24M	–	69
2022 Q1	$1.24M	Buy	302,852 +1,000	+0.3%	+$4.1K	0.1%	38
2021 Q4	$1.08M	Buy	301,852 +555	+0.2%	+$1.98K	0.08%	40
2021 Q3	$1.1M	Hold	301,297	–	–	0.09%	43
2021 Q2	$1.31M	Hold	301,297	–	–	0.1%	41
2021 Q1	$1.24M	Hold	301,297	–	–	0.11%	43
2020 Q4	$1.2M	Buy	301,297 +17,500	+6%	+$69.8K	0.11%	40
2020 Q3	$766K	Hold	283,797	–	–	0.08%	46
2020 Q2	$780K	Hold	283,797	–	–	0.09%	44
2020 Q1	$670K	Buy	283,797 +700	+0.2%	+$1.65K	0.09%	45
2019 Q4	$1.33M	Sell	283,097 -3,000	-1%	-$14.1K	0.14%	45
2019 Q3	$957K	Hold	286,097	–	–	0.1%	49
2019 Q2	$941K	Sell	286,097 -2,500	-0.9%	-$8.22K	0.1%	50
2019 Q1	$874K	Sell	288,597 -1,500	-0.5%	-$4.54K	0.09%	50
2018 Q4	$789K	Sell	290,097 -1,500	-0.5%	-$4.08K	0.1%	49
2018 Q3	$980K	Hold	291,597	–	–	0.11%	51
2018 Q2	$752K	Hold	291,597	–	–	0.09%	51
2018 Q1	$642K	Hold	291,597	–	–	0.07%	55
2017 Q4	$580K	Sell	291,597 -60,088	-17%	-$120K	0.05%	59
2017 Q3	$1.14M	Hold	351,685	–	–	0.1%	48
2017 Q2	$1.13M	Buy	351,685 +30,150	+9%	+$97K	0.1%	50
2017 Q1	$913K	Hold	321,535	–	–	0.08%	51
2016 Q4	$749K	Hold	321,535	–	–	0.07%	51
2016 Q3	$540K	Hold	321,535	–	–	0.05%	52
2016 Q2	$338K	Hold	321,535	–	–	0.03%	60
2016 Q1	$280K	Hold	321,535	–	–	0.02%	60
2015 Q4	$389K	Hold	321,535	–	–	0.03%	57
2015 Q3	$547K	Hold	321,535	–	–	0.05%	48
2015 Q2	$669K	Sell	321,535 -2,000	-0.6%	-$4.16K	0.05%	43
2015 Q1	$877K	Buy	323,535 +10,000	+3%	+$27.1K	0.06%	41
2014 Q4	$806K	Sell	313,535 -25,000	-7%	-$64.3K	0.06%	45
2014 Q3	$620K	Sell	338,535 -2,500	-0.7%	-$4.58K	0.05%	50
2014 Q2	$911K	Buy	341,035 +2,300	+0.7%	+$6.14K	0.08%	48
2014 Q1	$1.19M	Buy	338,735 +1,650	+0.5%	+$5.78K	0.1%	40
2013 Q4	$1.51M	Buy	337,085 +59,625	+21%	+$267K	0.14%	39
2013 Q3	$1.13M	Hold	277,460	–	–	0.11%	43
2013 Q2	$1.15M	Buy	+277,460	New	+$1.15M	0.12%	44